Big drugmakers aren’t doing as big deals as they had, mostly doing less risky bolt-ons under $10 billion

1 month ago 19

1. Homepage
2. Health
3. Big drugmakers aren’t doing as big deals as they had, mostly doing less risky bolt-ons under $10 billion